Search the Newsreel

Heron Therapeutics Inc (HRTX) Financial Health: Profitability & Balance Sheet Analysis

Heron Therapeutics Inc (HRTX) currently holds a financial score of 7.51, ranking 112 out of 385 in the Biotechnology & Medical Research industry, indicating a weak financial status despite high operating efficiency. The company's latest quarterly revenue decreased by 10.78% year-over-year to $34.71 million, …

Heron Therapeutics Inc Revenue Breakdown – BX:AXD2

Heron Therapeutics Inc (BX:AXD2) generated 122.80 million CHF in revenue last year, primarily from its Therapeutic Innovations segment, which slightly decreased from 131.04 million CHF the previous year. The United States was the largest contributor to this revenue.

Heron Therapeutics Schedules Aug. 10 Webcast for Q2 Results

Heron Therapeutics (Nasdaq: HRTX) will report its second-quarter 2026 financial results on Monday, August 10, 2026, at 8:30 a.m. ET. The company will host a conference call and live webcast to discuss these results and recent business highlights. Investors can access the event via …

Heron Therapeutics Inc (HRTX) Cash Flow

This article provides a detailed cash flow statement for Heron Therapeutics Inc (HRTX), including quarterly and annual data for operating, investing, and financing activities. It also includes frequently asked questions explaining different types of cash flow and how to interpret them for HRTX. Investors …

Heron Therapeutics Inc (AXD2) Q4 2022 Earnings Report - Results, Call & Slides

Heron Therapeutics Inc (AXD2) announced its Q4 2022 earnings, reporting an EPS of -€0.15 on revenue of €26.37M, beating analyst consensus for both metrics. The company's revenue grew 45.38% year-over-year. The next earnings date is estimated for August 11, 2026.

MoneyHero Limited (MNY) Stock Price, News, Quote & History

MoneyHero Limited (MNY) operating as a personal finance aggregation and comparison platform, is headquartered in Singapore and operates across several Asian markets. As of July 24, its stock closed at $0.96, experiencing a 4.00% decrease, while showing a 4.17% gain in after-hours trading. The …

HRTX|Heron Therapeutics Inc|Price:0.456|Chg%:-0.003

Heron Therapeutics Inc. (HRTX) is a commercial-stage biotechnology company trading at $0.456, experiencing a slight decline of 0.70%. The company is focused on improving patient lives through therapeutic innovations, particularly in acute care and oncology. Despite strong institutional ownership and high growth in revenue …

Top Gaines & Losers on 24 July: Syrma SGS Tech, HFCL, Swiggy, Eternal, Hero MotoCorp among top losers

Is Uber Technologies (UBER) Undervalued Following Its Delivery Hero Deal?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Event overview and why Uber Technologies stock is in focus Uber Technologies (UBER) is back in the spotlight after agreeing to acquire Delivery Hero in a deal …

SportsHero (ASX:SHO) Shares Fall 15%: Why Did the Digital Media Stock Lose Ground?

Hero MotoCorp (NSE:HEROMOTOCO) Could Be A Buy For Its Upcoming Dividend

Dara Khosrowshahi Says $14.8 Billion Delivery Hero Deal Will Double Uber's Mobility, Delivery Markets

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Ride-hailing giant Uber Technologies Inc. has reached an agreement to acquire German food delivery platform Delivery Hero SE in a deal worth $14.8 billion. Uber to Pay …

Delivery Hero (XTRA:DHER) Mulls Business Combination, Is It 15% Overvalued?

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Business combination call puts Delivery Hero in focus Delivery Hero (XTRA:DHER) is under the spotlight after a scheduled M&A call to discuss a proposed business combination agreement, …

Uber to Acquire Germany-Based Delivery Hero in $14.8 Billion Deal

This story was originally published on FSR. To receive daily news and insights, subscribe to our free daily FS Insider.The transaction is expected to close in the second half of 2027. Uber is making its biggest move yet in global food delivery. The company …

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Report - Results, Call & Slides

Heron Therapeutics (HRTX) reported strong Q1 2024 earnings, beating both EPS and revenue expectations. The company recorded an actual EPS of -$0.02 against a consensus of -$0.07, and revenue of $34.67 million, surpassing the expected $32.98 million. The report also highlights a significant year-over-year …

Delivery Hero schließt Business Combination Agreement mit Uber Technologies sowie einen Kaufvertrag mit SSW Partners betreffend bestimmte Geschäftsbereiche ab

MoneyHero Group Reports Unaudited First Quarter 2026 Results

MoneyHero Limited's (NASDAQ:MNY) Profit Outlook

Heron Therapeutics (HRTX) Quarterly Loss Revives Dilution Fears And Tests Profitability Narrative

Heron Therapeuti earnings missed by $0.02, revenue fell short of estimates

Earnings call transcript: Heron Therapeutics Q1 2026 results miss forecasts, stock drops

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Analysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out for

HERON THERAPEUTICS ($HRTX) Releases Q4 2025 Earnings

Is MoneyHero (NASDAQ:MNY) In A Good Position To Deliver On Growth Plans?

Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Catapults 27% Though Its Price And Business Still Lag The Industry

Market Sentiment Around Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX)

Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported, And Analysts Assigned A US$4.50 Price Target

Heron Therapeutics (HRTX): Forecasts Signal 60.89% Annual Earnings Growth, Path to Profitability in Focus

Sinyal Akuisisi dan Aksi Hero Global Investment (HGII) ke Proyek Energi Sampah

Heron Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Corporate Updates

Earnings call transcript: Heron Therapeutics beats Q1 2025 expectations, stock surges

Heron Therapeutics (HRTX) Stock Price, News & Analysis

Intip Ekspansi Hero Global (HGII) Kejar Kapasitas EBT 100 MW pada 2031

Emiten Energi Hero Global Investment HGII Siap IPO, Ini Prospeknya

MoneyHero (MNY) Earnings Date and Reports 2026 $MNY